Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.21444 | 8 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.20656 | 9 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.20436 | 8 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.15355 | 8 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.17725 | 9 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.2432 | 8 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.19768 | 8 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.45397 | 20 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.18741 | 9 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.18751 | 8 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.18217 | 8 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.18701 | 9 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.20326 | 9 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.1903 | 8 |